- Gastrointestinal permeability - a parameter of possible prognostic importance in metastatic colorectal carcinoma2008 | Central Library of Charles University
- Gastrointestinal permeability - a parameter of possible prognostic importance in metastatic colorectal carcinoma2008 | Faculty of Pharmacy in Hradec Králové
- Sarcopenia in Metastatic Colorectal Carcinoma2019 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression(aEuro)2016 | Publication without faculty affiliation
- Cetuximab in the treatment of metastatic colorectal carcinoma - case studies2017 | First Faculty of Medicine
- Hypomagnesaemia in patients with metastatic colorectal carcinoma treated with cetuximab2012 | Faculty of Medicine in Hradec Králové
- Treatment of metastatic colorectal carcinoma - 3rd line and abovePublication without faculty affiliation
- Trifluridine/tipiracil treatment in a patient with mucinous metastatic colorectal carcinoma2022 | Third Faculty of Medicine
- Metastatic colorectal carcinoma and kidney tumors: a report of four cases2010 | Faculty of Medicine in Hradec Králové
- Lonsurf plus bevacizumab: A new standard in the third-line treatment of metastatic colorectal carcinoma2023 | Publication without faculty affiliation
- Urinary Neopterin Concentrations During Combination Therapy with Cetuximab in Previously Treated Patients with Metastatic Colorectal Carcinoma2014 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Skin toxicity treatment with a metastatic colorectal carcinoma patient cured with cetuximab - a clinical case report2012 | Faculty of Medicine in Pilsen
- Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin2009 | Central Library of Charles University
- Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin2009 | First Faculty of Medicine
- KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma2011 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma2011 | First Faculty of Medicine
- Administration of raltitrexed in patients with metastatic colorectal carcinoma is not associated with increased intestinal permeability2001 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Circulating tumor DNA as a biomarker in metastatic colorectal carcinoma - case report2020 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
- Concordance of DNA copy number profiles between primary and metastatic colorectal carcinoma2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Efficacy and Toxicity of Bevacizumab on Combination with Chemotherapy in Different Lines of Treatment for Metastatic Colorectal Carcinoma2014 | First Faculty of Medicine
- Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry2015 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Serum Uric Acid and C-reactive Protein in Patients with Metastatic Colorectal Carcinoma During Combination Therapy with High-dose Folinic Acid2012 | Faculty of Medicine in Hradec Králové
- Possibilities of the prognosis assessment in patients with metastatic colorectal carcinoma based on the peripheral blood leukocytes imunophenotype +1Publication without faculty affiliation
- Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Association of peripheral blood cell count-derived ratios, biomarkers of inflammatory response and tumor growth with outcome in previously treated metastatic colorectal carcinoma patients receiving cetuximab2017 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab2010 | Central Library of Charles University
- Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab2010 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis2014 | First Faculty of Medicine
- Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study2019 | Publication without faculty affiliation
